Christopher Sampson, BA (Hons), MSc, PhD
Principal Economist, Office of Health Economics (London, UK). Former Co-Chair, ISPOR Open Source Models SIG. Modeler

J. Robert Beck, MD
Former Deputy Director, Fox Chase Cancer Center (Philadelphia, PA) and Co-Founder, Society for Medical Decision Making. Modeler

Andrew Briggs, PhD
Professor of Health Economics and Co-Director, Global Health Economics (GHECO) Centre, London School of Hygiene & Tropical Medicine. Co-Chair, ISPOR/SMDM Task Force on Modeling Methods. Modeler

Mark Roberts, MD, MPP
Professor of Medicine, Health Policy & Management, and Industrial Engineering; Chief, Section of Decision Sciences & Clinical Systems Modeling, University of Pittsburgh. Modeler

Ron Handels, PhD
Health Scientist and Epidemiologist, Maastricht University (Netherlands). Modeler

Raymond Henderson, PhD, MSc
Senior HTA Manager, Salutem Insights (Dublin, Ireland). Modeler

Joseph DiCesare, RPh, MPH
Former Lead, Real World Evidence & Economic Modeling, Allergan Pharmaceuticals; former VP, Global HEOR, Novartis Pharma.

Xavier Pouwels, PhD
Researcher, University of Twente, Health Technology & Services Research (Netherlands). Modeler

Talitha Feenstra, PhD
Associate Professor, Groningen University & National Institute for Public Health and the Environment (RIVM, Netherlands). Co-developer of the AdViSHE validation tool. Modeler

Aryana Sepassi, PharmD, MAS
Assistant Professor of Clinical Pharmacy Practice, UC Irvine School of Pharmacy & Pharmaceutical Sciences.

Natalia Kunst, PhD
Senior Research Fellow & Associate Professor, Centre for Health Economics, University of York. Evaluator for NICE; ISPOR Model Validation Task Force member. Modeler

Michael Drummond, BSc, MCom, DPhil
Professor of Health Economics (Emeritus), University of York. ISPOR Past President; former Co-Editor of Value in Health. Emeritus Advisor